SCoV-2 Ag Detect™ Rapid Test
In Development

The SCoV-2 Ag Detect™ Rapid Test is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen. The test can be performed using direct nasal samples (from individuals who are suspected of COVID-19 by their healthcare provider) collected without transport media, requires minimal training to perform, and takes less than 30 minutes to obtain results, making it a suitable diagnostic tool for use in a point-of-care setting.